The company said it moved Image Guided Therapies (IGT) from the Imaging segment to the Ultrasound segment effective July 1, 2024, and that the segment was later renamed Advanced Visualization Solutions (AVS). The company said the change was made to better match IGT's clinical usage.

8-KRegulation FD DisclosureFiled Oct 30, 2024Period of report Oct 30, 2024Summary published (UTC) Oct 25, 2026

Key points

AI summary

The company said it moved Image Guided Therapies (IGT) from the Imaging segment to the Ultrasound segment effective July 1, 2024, and that the segment was later renamed Advanced Visualization Solutions (AVS). The company said the change was made to better match IGT's clinical usage.
The company said it continues to have four reportable segments after the realignment: Imaging, AVS, PCS, and PDx. It said the recast unaudited financial information is provided to aid comparability and has no impact on previously reported consolidated or combined financial statements for any period.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call. Some paragraphs were omitted because their support in the source could not be confirmed.

Moving IGT from Imaging to AVS

The company said it moved Image Guided Therapies (IGT) from the Imaging segment to the Ultrasound segment effective July 1, 2024, and that the segment was later renamed Advanced Visualization Solutions (AVS). The company said the change was made to better match IGT's clinical usage.

Source · Based on the filing body and exhibits

Keeping 4 reportable segments and the nature of the recast data

The company said it continues to have four reportable segments after the realignment: Imaging, AVS, PCS, and PDx. It said the recast unaudited financial information is provided to aid comparability and has no impact on previously reported consolidated or combined financial statements for any period.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.